Development of SARS-CoV-2 specific neutralizing antibodies with high binding affinity

Development of SARS-CoV-2 specific neutralizing antibodies with high binding affinity

The global coronavirus (COVID-19) disease pandemic is caused by a novel virus, SARS-CoV-2. To fully understand this new virus there is an urgent need for scientific research reagents, particularly antibodies, which bind to targets on the viral surface.